Skip to content
2000
Volume 5, Issue 3
  • ISSN: 1872-2148
  • E-ISSN: 2212-3334

Abstract

The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.

Loading

Article metrics loading...

/content/journals/emi/10.2174/187221411797265953
2011-09-01
2025-09-13
Loading full text...

Full text loading...

/content/journals/emi/10.2174/187221411797265953
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test